Abdumalik Nigmatovich Aripov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdumalik Nigmatovich Aripov has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Lola Lazizovna Akhunzhanova
Department of Clinical Laboratory diagnostics of Republican Specialized Scientific and Practical Medical Center of Pediatrics of the Ministry of Health of the Republic of Uzbekistan, Tashkent City, Uzbekistan
2 shared publications - Orifzhon Abdumalikovich Aripov
Department of Clinical Laboratory diagnostics of Republican Specialized Scientific and Practical Medical Center of Pediatrics of the Ministry of Health of the Republic of Uzbekistan, Tashkent City, Uzbekistan
2 shared publications - Tolmas Tolibovich Khamroev
Department of pharmacology and toxicology of the Institute of Chemistry of Plant Substances named after Academician S.Yu. Yunusov of the Academy of Sciences of the Republic of Uzbekistan, Tashkent City, Uzbekistan
2 shared publications - Abdusamad Utkirovich Nabiev
Department of Clinical Laboratory diagnostics of Republican Specialized Scientific and Practical Medical Center of Pediatrics of the Ministry of Health of the Republic of Uzbekistan, Tashkent City, Uzbekistan
1 shared publication
Latest Publications
- Open Access
- 20 March 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 1 (19) , 511-523
Determination of the Simultaneous Hepatoprotective and Antidepressant Activity of the Composition Hepalipin and Yantacin
Although only a few groups of drugs with hepatoprotective activity are recognized, the introduction of drugs with high liver protective activity, mainly based on natural compounds or plants, has become an urgent problem especially, over the last twenty years. A striking example of this is the fact that the hepatoprotective activity of existing phytotherapeutic drugs is not as high as that of synthetic drugs. However, secondary plant metabolites, including flavonoids, flavones, flavonols, and other naturally occurring biologically active compounds, are becoming a promising therapeutic alternative to traditional medicines in modern medicine. The priority purpose of this study is to introduce a new highly hepatoprotective and at the same time biologically active antidepressant of a new composition based on a combination of phospholipid, lycopene, glycerisic acid and yantacin obtained from plants. All of the research was done on rats, and the administration of heliothrin, a chemical that has a hepatotoxic effect, into the abdominal cavity in accordance with a rigorous plan resulted in significant chronic liver damage. Its hepatoprotector and antidepressant properties were compared to those of the well-known medication Phosphogliv and fluoxetine, which are both commonly used in medicine. The study's focus was a 1:1 mixture of heparin and yanatacin. As a result, the pharmacological composition that is being presented is completely safe, and research has shown that its constituents exhibit a markedly elevated activity not only in relation to the well-known medication phosphogliv, but also in relation to the ecdysteroid form of yantacin and hepalipin. Consequently, the pharmacological composition offered is entirely safe, and studies have demonstrated that its components have significantly higher activity not only when compared to the well-known drug phosphogliv, but also when compared to the ecdystenic form of yantacin and hepalipin.
- 20 March 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 1 (19) , 511-523
Open AccessDetermination of the Simultaneous Hepatoprotective and Antidepressant Activity of the Composition Hepalipin and Yantacin
Although only a few groups of drugs with hepatoprotective activity are recognized, the introduction of drugs with high liver protective activity, mainly based on natural compounds or plants, has become an urgent problem especially, over the last twenty years. A striking example of this is the fact that the hepatoprotective activity of existing phytotherapeutic drugs is not as high as that of synthetic drugs. However, secondary plant metabolites, including flavonoids, flavones, flavonols, and other naturally occurring biologically active compounds, are becoming a promising therapeutic alternative to traditional medicines in modern medicine. The priority purpose of this study is to introduce a new highly hepatoprotective and at the same time biologically active antidepressant of a new composition based on a combination of phospholipid, lycopene, glycerisic acid and yantacin obtained from plants. All of the research was done on rats, and the administration of heliothrin, a chemical that has a hepatotoxic effect, into the abdominal cavity in accordance with a rigorous plan resulted in significant chronic liver damage. Its hepatoprotector and antidepressant properties were compared to those of the well-known medication Phosphogliv and fluoxetine, which are both commonly used in medicine. The study's focus was a 1:1 mixture of heparin and yanatacin. As a result, the pharmacological composition that is being presented is completely safe, and research has shown that its constituents exhibit a markedly elevated activity not only in relation to the well-known medication phosphogliv, but also in relation to the ecdysteroid form of yantacin and hepalipin. Consequently, the pharmacological composition offered is entirely safe, and studies have demonstrated that its components have significantly higher activity not only when compared to the well-known drug phosphogliv, but also when compared to the ecdystenic form of yantacin and hepalipin.
- Open Access
- 30 September 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (3) , 1815-1825
Antifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- 30 September 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (3) , 1815-1825
Open AccessAntifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.